§ 13F · FUND PROFILE
Decheng Capital LLC.
AUM · $732M (13F)Positions · 14Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$625K deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | CGON | CG ONCOLOGY INC | 6.37M | $453M | 61.9% | ±0% |
| 2 | NUVB | Nuvation Bio Inc. | 25.95M | $147M | 20.1% | ±0% |
| 3 | AARD | AARDVARK THERAPEUTICS INC | 3.92M | $23M | 3.1% | ±0% |
| 4 | ACRS | Aclaris Therapeutics, Inc. | 4.04M | $21M | 2.9% | ±0% |
| 5 | UPB | Upstream Bio Inc. | 2.72M | $19M | 2.6% | ±0% |
| 6 | RCUS | Arcus Biosciences, Inc | 465K | $14M | 2.0% | −3% |
| 7 | EQ | Equillium Inc. | 4.45M | $14M | 1.9% | ±0% |
| 8 | RVMD | REVOLUTION MEDICINES INC(NSM) | 53K | $10M | 1.3% | −44% |
| 9 | LYEL | Lyell Immunopharma, Inc. | 692K | $10M | 1.3% | ±0% |
| 10 | BYSI | BeyondSpring Inc. | 3.80M | $7M | 0.9% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE DECHENG SIGNAL
AC read
Decheng Capital LLC is a Other fund managing $732 million in assets. The fund runs a focused portfolio of just 14 positions.
Read the full dossier →